PURPOSE: This systematic review represents a thorough evaluation of the literature to clarify the impact of cancer therapies on the prevalence, quality of life and economic impact, and management strategies for cancer-therapy-induced trismus. METHODS: A systematic literature search was conducted with assistance from a research librarian in the databases MEDLINE/PubMed and EMBASE for articles published between January 1, 1990 and December 31, 2008. Each study was independently assessed by two reviewers. Taking into account predetermined quality measures, a weighted prevalence was calculated for the prevalence of trismus. The level of evidence, recommendation grade, and guideline (if possible) were given for published preventive and management strategies for trismus. RESULTS: We reviewed a total of 22 published studies between 1990 and 2008. Most of them assessed the prevalence of this complication, and few focused on management. The weighted prevalence for trismus was 25.4% in patients who received conventional radiotherapy and 5% for the few intensity-modulated radiation therapy studies. No clear guideline recommendations could be made for the prevention or management of trismus. CONCLUSIONS: Newer radiation modalities may decrease the prevalence of trismus compared to conventional radiotherapy. Few studies have addressed the quality of life impact of trismus, and no studies were identified to assess the economic impact of trismus. The few preventive and management trials identified in the literature showed some promise, although larger, well-designed studies are required to appropriately assess these therapies before recommendations can be provided.
PURPOSE: This systematic review represents a thorough evaluation of the literature to clarify the impact of cancer therapies on the prevalence, quality of life and economic impact, and management strategies for cancer-therapy-induced trismus. METHODS: A systematic literature search was conducted with assistance from a research librarian in the databases MEDLINE/PubMed and EMBASE for articles published between January 1, 1990 and December 31, 2008. Each study was independently assessed by two reviewers. Taking into account predetermined quality measures, a weighted prevalence was calculated for the prevalence of trismus. The level of evidence, recommendation grade, and guideline (if possible) were given for published preventive and management strategies for trismus. RESULTS: We reviewed a total of 22 published studies between 1990 and 2008. Most of them assessed the prevalence of this complication, and few focused on management. The weighted prevalence for trismus was 25.4% in patients who received conventional radiotherapy and 5% for the few intensity-modulated radiation therapy studies. No clear guideline recommendations could be made for the prevention or management of trismus. CONCLUSIONS: Newer radiation modalities may decrease the prevalence of trismus compared to conventional radiotherapy. Few studies have addressed the quality of life impact of trismus, and no studies were identified to assess the economic impact of trismus. The few preventive and management trials identified in the literature showed some promise, although larger, well-designed studies are required to appropriately assess these therapies before recommendations can be provided.
Authors: K Sultanem; H K Shu; P Xia; C Akazawa; J M Quivey; L J Verhey; K K Fu Journal: Int J Radiat Oncol Biol Phys Date: 2000-10-01 Impact factor: 7.038
Authors: Romuald Le Scodan; Pascal Pommier; Jean Michel Ardiet; Xavier Montbarbon; Claude Malet; Véronique Favrel; Philippe Zrounba; Marc Poupart; Philippe Céruse; Céline Ferlay; Sébastien Clippe Journal: Int J Radiat Oncol Biol Phys Date: 2005-10-01 Impact factor: 7.038
Authors: Dana M Hartl; Myriam Cohen; Morbize Juliéron; Patrick Marandas; Franéois Janot; Jean Bourhis Journal: Otolaryngol Head Neck Surg Date: 2008-04 Impact factor: 3.497
Authors: Peter Levendag; Wideke Nijdam; Inge Noever; Paul Schmitz; Marjan van de Pol; Dick Sipkema; Cora Braat; Maarten de Boer; Peter Jansen Journal: Int J Radiat Oncol Biol Phys Date: 2004-07-01 Impact factor: 7.038
Authors: L J Melchers; E Van Weert; C H G Beurskens; H Reintsema; A P Slagter; J L N Roodenburg; P U Dijkstra Journal: Int J Oral Maxillofac Surg Date: 2009-05-02 Impact factor: 2.789
Authors: Laurelie R Wall; Sanjeewa Kularatna; Elizabeth C Ward; Bena Cartmill; Anne J Hill; Elizabeth Isenring; Joshua Byrnes; Sandro V Porceddu Journal: Dysphagia Date: 2018-12-04 Impact factor: 3.438
Authors: Matthew J Krasin; Kristin M Wiese; Sheri L Spunt; Chia-Ho Hua; Najat Daw; Fariba Navid; Andrew M Davidoff; Lisa McGregor; Thomas E Merchant; Larry E Kun; Lola McCrarey; Kelly A Hoth; Xiaowei Yan; Xiaoping Xiong Journal: Int J Radiat Oncol Biol Phys Date: 2010-11-17 Impact factor: 7.038
Authors: Michael K Ghiam; Kyle Mannion; Mary S Dietrich; Kristen L Stevens; Jill Gilbert; Barbara A Murphy Journal: Support Care Cancer Date: 2017-02-13 Impact factor: 3.603
Authors: Michael T Brennan; Nathaniel S Treister; Thomas P Sollecito; Brian L Schmidt; Lauren L Patton; Kusha Mohammadi; Leslie Long Simpson; Helen Voelker; James S Hodges; Rajesh V Lalla Journal: J Am Dent Assoc Date: 2017-12 Impact factor: 3.634
Authors: Primož Strojan; Katherine A Hutcheson; Avraham Eisbruch; Jonathan J Beitler; Johannes A Langendijk; Anne W M Lee; June Corry; William M Mendenhall; Robert Smee; Alessandra Rinaldo; Alfio Ferlito Journal: Cancer Treat Rev Date: 2017-07-18 Impact factor: 12.111